跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
氨酚双氢可待因片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Paracetamol and Dihydrocodeine Tartrate Tablets
Approved
化学药品
Paracetamol and Dihydrocodeine Tartrate Tablets
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
May 26, 2021
Approval ID
8BYsBA1ij3A
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
8BYsBA1ij3A
Approval Number
国药准字HC20160026
Generic Name
氨酚双氢可待因片
Generic Name En
Paracetamol and Dihydrocodeine Tartrate Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含对乙酰氨基酚500mg与酒石酸双氢可待因10mg
Reg Date
2021-05-26
Expired Date
2026-05-25
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街1号澳美制药中心
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 26, 2021
Approval ID
8BYsBA1ij3A
Type
化学药品
Back to NMPA Approvals